Table 2.
Overview of selected health utilities measures applied in adults with HIV/AIDS
| Measures | Country of origin | Domain | No. items | Response options | No. health states | Ranges | Endpoints | Admin (time) | |
|---|---|---|---|---|---|---|---|---|---|
| 1 (100) | 0 | ||||||||
| 1. EQ-5D-3L(EuroQol -five dimensions-3 levels) | EuroQoL Group | mobility, self-care, usual activities, pain/discomfort and anxiety/depression | 5 | 3 levels | 243 | −0.59 to 1.00 | full health | death | I, SA* (2 mins) |
| 2. EQ-5D-5L(EuroQol -five dimensions-5 levels) | EuroQoL Group | mobility, self-care, usual activities, pain/discomfort and anxiety/depression | 5 | 5 levels | 3125 | −0.45 to 1.00 | full health | death | I, SA* (2 mins) |
| 3. 15D | Finland | breathing, mental function, speech (communication), vision, mobility, usual activities, vitality, hearing, eating, elimination, sleeping, distress, discomfort and symptoms, sexual activity, and depression | 15 | 5 levels | 31 billions | 0.00 to 1.00 | full health | death | I, SA* (5–10 mins) |
| 4. Health Utility Index Mark 2 (HUI2) | Canada | sensation, mobility, emotion, cognition, self-care, pain and fertility | 7 | 3-5 levels | 972,000 | −0.02 to 1.00 | full health | death | I, SA* (5–10 mins) |
| 5. Health Utility Index Mark 3 (HUI3) | Canada | Vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain | 8 | 5–6 levels | 972,000 | −0.36 to 1.00 | full health | death | I, SA* (5–10 mins) |
| 6. Short form 6 (SF-6D) | UK | physical functioning; role limitations; social functioning; pain; mental health and vitality | 11 | 4-6 levels | 18000 | 0.00 to 1.00 | best health state | worst health state | I, SA* (2 mins) |
| 7. Standard Gamble (SG) | USA | - | - | Continuous | - | 0.00 to 1.00 | full health | death | I, SA* (2 mins) |
| 8. Time trade-off (TTO) | USA | - | - | Continuous | - | 0.00 to 1.00 | full health | death | I, SA* (2 mins) |
| 9. Visual analog scale (VAS) | EuroQoL Group | - | - | Continuous | - | 0 to 100 | full health | worst health | I, SA* (1 mins) |
*I: Interview, SA: Self-administered.